T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
EVgo
EVGO
$196M
| $436K | ﹤0.01% |
227,771
+69,997
| +44% | +$141K |
|
|
DRUG
2677
Bright Minds Biosciences
DRUG
$508M
| $433K | ﹤0.01% |
6,167
+1,220
| +25% | +$95.8K |
|
2678
Angi Inc
ANGI
$220M
| $432K | ﹤0.01% |
72,545
+5,237
| +8% | +$32.3K |
|
2679
Lyell Immunopharma
LYEL
$241M
| $431K | ﹤0.01% |
30,657
+17,529
| +134% | +$317K |
|
2680
Ocugen
OCGN
$346M
| $430K | ﹤0.01% |
+280,639
| New | +$427K |
|
2681
Westwood Holdings Group
WHG
$182M
| $430K | ﹤0.01% |
22,413
+4,311
| +24% | +$72.5K |
|
2682
HBT Financial
HBT
$1.32B
| $428K | ﹤0.01% |
13,358
+5,297
| +66% | +$152K |
|
2683
First US Bancshares
FUSB
$90.5M
| $427K | ﹤0.01% |
25,753
+5,339
| +26% | +$85.6K |
|
|
URG
2684
Ur-Energy
URG
$450M
| $426K | ﹤0.01% |
+312,648
| New | +$510K |
|
2685
Achieve Life Sciences
ACHV
$776M
| $423K | ﹤0.01% |
+64,769
| New | +$309K |
|
2686
AdvanSix
ASIX
$427M
| $421K | ﹤0.01% |
21,143
+810
| +4% | +$18.2K |
|
|
CHCT
2687
Community Healthcare Trust
CHCT
$413M
| $421K | ﹤0.01% |
23,015
+4,346
| +23% | +$75.5K |
|
2688
PubMatic
PUBM
$847M
| $421K | ﹤0.01% |
32,040
+1,114
| +4% | +$11.6K |
|
|
NUAI
2689
New Era Energy & Digital Inc
NUAI
$853M
| $421K | ﹤0.01% |
+65,970
| New | +$320K |
|
2690
First Business Financial Services
FBIZ
$590M
| $420K | ﹤0.01% |
6,641
+1,200
| +22% | +$69.5K |
|
2691
Natural Gas Services Group
NGS
$423M
| $420K | ﹤0.01% |
9,730
+1,712
| +21% | +$69.6K |
|
2692
Nu Skin
NUS
$225M
| $420K | ﹤0.01% |
79,403
+9,710
| +14% | +$62.1K |
|
2693
Ardmore Shipping
ASC
$729M
| $418K | ﹤0.01% |
29,802
+5,717
| +24% | +$97K |
|
|
RMAX
2694
DELISTED
RE/MAX Holdings
RMAX
| $416K | ﹤0.01% |
42,161
+7,252
| +21% | +$63.3K |
|
|
LENZ
2695
LENZ Therapeutics
LENZ
$123M
| $416K | ﹤0.01% |
73,181
+33,560
| +85% | +$271K |
|
2696
York Water
YORW
$503M
| $415K | ﹤0.01% |
13,530
+3,620
| +37% | +$109K |
|
2697
Cable One
CABO
$83.1M
| $414K | ﹤0.01% |
7,795
+568
| +8% | +$38.1K |
|
2698
Dakota Gold
DC
$887M
| $414K | ﹤0.01% |
97,175
+27,651
| +40% | +$149K |
|
2699
Greif Class B
GEF.B
$4.1B
| $414K | ﹤0.01% |
4,424
-820
| -16% | -$69.3K |
|
|
ILPT
2700
Industrial Logistics Properties Trust
ILPT
$492M
| $414K | ﹤0.01% |
46,655
+8,361
| +22% | +$64.8K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.